Medicover AB (publ)

STO-MCOV.B
Nasdaq Stockholm
Healthcare Medical Care Facilities
Global Rank
#3817
Country Rank
#52
Market Cap
4.22 B
Price
27.96
Change (%)
0.00%
Volume
52,370

Medicover AB (publ)'s latest marketcap:

4.22 B

As of 08/11/2025, Medicover AB (publ)'s market capitalization has reached $4.22 B. According to our data, Medicover AB (publ) is the 3817th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 4.22 B
Revenue (ttm) 2.63 B
Net Income (ttm) 50.56 M
Shares Out 150.98 M
EPS (ttm) 0.34
Forward PE 42.36
Ex-Dividend Date 04/30/2025
Earnings Date 07/24/2025
Market Cap Chart
Data Updated: 08/11/2025

Medicover AB (publ)'s yearly market capitalization.

Medicover AB (publ) has seen its market value grow from kr8.4 B to kr40.46 B since 2017, representing a total increase of 381.69% and an annual compound growth rate (CAGR) of 22.92%.
Date Market Cap(kr) Market Cap(USD) Change (%) Global Rank
08/11/2025 kr40.46 B $4.22 B 40.36% 3817
12/30/2024 kr28.83 B $2.59 B 28.33% 4802
12/29/2023 kr22.46 B $2.21 B 7.84% 5273
12/30/2022 kr20.83 B $1.99 B -62.3% 5393
12/30/2021 kr55.25 B $6.08 B 127.1% 2751
12/30/2020 kr24.33 B $2.94 B 68% 4190
12/30/2019 kr14.48 B $1.54 B 48.16% 5339
12/28/2018 kr9.77 B $1.1 B 16.35% 5825
12/29/2017 kr8.4 B $1.02 B 7033

Company Profile

About Medicover AB (publ)

Medicover AB (publ) is a leading provider of healthcare and diagnostic services, operating in Poland, India, Romania, Sweden, and internationally.

Healthcare Services

The company offers a comprehensive range of healthcare solutions, including:

  • Outpatient and inpatient care
  • Dental services
  • Hospital care
  • Preventive care
  • Wellness services and non-medical offerings (sports memberships, benefit cards, optics)

Diagnostic Services

Medicover provides advanced laboratory testing across all major clinical pathology areas, from routine to specialized tests. Key diagnostic services include:

  • Allergy and autoimmune diagnostics
  • Bacteriology and parasitology
  • Biochemistry and immunochemistry
  • Blood group diagnostics/transfusion medicine
  • Tumour markers and clinical chemistry
  • Cytology, haematology, and histopathology
  • Human genetics and molecular biology
  • Infectious disease testing
  • Pharmacology/toxicology

Customer Base

The company serves a diverse clientele, including:

  • Corporate clients
  • Individual patients
  • Public payers

Founded: 1995
Headquarters: Stockholm, Sweden

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.